Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131597) titled 'Clinical Application of 18F-FES and 18F-FDG Dual-Tracer Imaging in ER-Positive Tumors' on Sept. 4.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: The First Affiliated Hospital of Dalian Medical University
Condition:
ER-positive tumors, uterine fibroids
Intervention:
Gold Standard:Pathological section ER staining
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2023-01-13
Target Sample Size: Target condition:20;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=326684...